nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—GRIA4—cerebellar cortex—malignant glioma	0.0381	0.0964	CbGeAlD
Topiramate—GRIK1—cerebellar cortex—malignant glioma	0.0334	0.0845	CbGeAlD
Topiramate—GRIK1—telencephalic ventricle—malignant glioma	0.0194	0.0492	CbGeAlD
Topiramate—GRIA1—cerebellar cortex—malignant glioma	0.0166	0.042	CbGeAlD
Topiramate—GRIK2—cerebellar cortex—malignant glioma	0.0119	0.0301	CbGeAlD
Topiramate—GRIA1—telencephalic ventricle—malignant glioma	0.00965	0.0244	CbGeAlD
Topiramate—GRIK2—telencephalic ventricle—malignant glioma	0.00693	0.0175	CbGeAlD
Topiramate—GRIK4—telencephalon—malignant glioma	0.00674	0.017	CbGeAlD
Topiramate—GRIA4—brainstem—malignant glioma	0.006	0.0152	CbGeAlD
Topiramate—GRIA4—retina—malignant glioma	0.00579	0.0146	CbGeAlD
Topiramate—GRIK5—brainstem—malignant glioma	0.00554	0.014	CbGeAlD
Topiramate—GRIK3—retina—malignant glioma	0.00534	0.0135	CbGeAlD
Topiramate—GRIA4—telencephalon—malignant glioma	0.00532	0.0135	CbGeAlD
Topiramate—GRIK1—brainstem—malignant glioma	0.00526	0.0133	CbGeAlD
Topiramate—GRIK1—retina—malignant glioma	0.00507	0.0128	CbGeAlD
Topiramate—GRIK5—telencephalon—malignant glioma	0.00491	0.0124	CbGeAlD
Topiramate—GRIK3—telencephalon—malignant glioma	0.00491	0.0124	CbGeAlD
Topiramate—GRIK1—telencephalon—malignant glioma	0.00467	0.0118	CbGeAlD
Topiramate—GRIA3—telencephalon—malignant glioma	0.00434	0.011	CbGeAlD
Topiramate—GRIA4—medulla oblongata—malignant glioma	0.00418	0.0106	CbGeAlD
Topiramate—GRIK3—medulla oblongata—malignant glioma	0.00386	0.00976	CbGeAlD
Topiramate—GRIK5—medulla oblongata—malignant glioma	0.00386	0.00976	CbGeAlD
Topiramate—GRIK4—central nervous system—malignant glioma	0.00383	0.00968	CbGeAlD
Topiramate—GRIK4—cerebellum—malignant glioma	0.00374	0.00946	CbGeAlD
Topiramate—GRIA4—spinal cord—malignant glioma	0.00373	0.00943	CbGeAlD
Topiramate—GRIK1—medulla oblongata—malignant glioma	0.00367	0.00928	CbGeAlD
Topiramate—GRIK5—midbrain—malignant glioma	0.00353	0.00892	CbGeAlD
Topiramate—GRIK3—midbrain—malignant glioma	0.00353	0.00892	CbGeAlD
Topiramate—GRIK5—spinal cord—malignant glioma	0.00344	0.00871	CbGeAlD
Topiramate—GRIK3—spinal cord—malignant glioma	0.00344	0.00871	CbGeAlD
Topiramate—GRIA3—medulla oblongata—malignant glioma	0.00341	0.00862	CbGeAlD
Topiramate—GRIK1—midbrain—malignant glioma	0.00335	0.00848	CbGeAlD
Topiramate—GRIK1—spinal cord—malignant glioma	0.00327	0.00827	CbGeAlD
Topiramate—GRIA3—midbrain—malignant glioma	0.00312	0.00788	CbGeAlD
Topiramate—GRIA3—spinal cord—malignant glioma	0.00304	0.00769	CbGeAlD
Topiramate—GRIK4—brain—malignant glioma	0.00304	0.00769	CbGeAlD
Topiramate—GRIA4—central nervous system—malignant glioma	0.00303	0.00765	CbGeAlD
Topiramate—GRIA4—cerebellum—malignant glioma	0.00296	0.00748	CbGeAlD
Topiramate—GRIK5—central nervous system—malignant glioma	0.00279	0.00706	CbGeAlD
Topiramate—GRIK3—central nervous system—malignant glioma	0.00279	0.00706	CbGeAlD
Topiramate—GRIK5—cerebellum—malignant glioma	0.00273	0.0069	CbGeAlD
Topiramate—GRIK3—cerebellum—malignant glioma	0.00273	0.0069	CbGeAlD
Topiramate—GRIK1—central nervous system—malignant glioma	0.00265	0.00671	CbGeAlD
Topiramate—GRIA1—brainstem—malignant glioma	0.00261	0.0066	CbGeAlD
Topiramate—GRIK1—cerebellum—malignant glioma	0.00259	0.00656	CbGeAlD
Topiramate—GRIA1—retina—malignant glioma	0.00252	0.00637	CbGeAlD
Topiramate—GRIA3—central nervous system—malignant glioma	0.00247	0.00624	CbGeAlD
Topiramate—GRIA3—cerebellum—malignant glioma	0.00241	0.0061	CbGeAlD
Topiramate—GRIA4—brain—malignant glioma	0.0024	0.00608	CbGeAlD
Topiramate—Influenza-like symptoms—Temozolomide—malignant glioma	0.00236	0.0057	CcSEcCtD
Topiramate—Flat affect—Temozolomide—malignant glioma	0.00233	0.00564	CcSEcCtD
Topiramate—Stupor—Carmustine—malignant glioma	0.00233	0.00564	CcSEcCtD
Topiramate—GRIA1—telencephalon—malignant glioma	0.00232	0.00586	CbGeAlD
Topiramate—Scotoma—Carmustine—malignant glioma	0.00229	0.00554	CcSEcCtD
Topiramate—Vaginal haemorrhage—Temozolomide—malignant glioma	0.00227	0.0055	CcSEcCtD
Topiramate—Menorrhagia—Temozolomide—malignant glioma	0.00227	0.0055	CcSEcCtD
Topiramate—GRIA2—embryo—malignant glioma	0.00226	0.00572	CbGeAlD
Topiramate—GRIK5—brain—malignant glioma	0.00222	0.00561	CbGeAlD
Topiramate—GRIK3—brain—malignant glioma	0.00222	0.00561	CbGeAlD
Topiramate—Scotoma—Temozolomide—malignant glioma	0.00222	0.00536	CcSEcCtD
Topiramate—Otitis media—Temozolomide—malignant glioma	0.00216	0.00523	CcSEcCtD
Topiramate—Coagulopathy—Temozolomide—malignant glioma	0.00216	0.00523	CcSEcCtD
Topiramate—Hyperaesthesia—Temozolomide—malignant glioma	0.00214	0.00518	CcSEcCtD
Topiramate—Memory impairment—Temozolomide—malignant glioma	0.00214	0.00518	CcSEcCtD
Topiramate—GRIK1—brain—malignant glioma	0.00211	0.00533	CbGeAlD
Topiramate—GRIA2—brainstem—malignant glioma	0.00207	0.00525	CbGeAlD
Topiramate—Rigors—Temozolomide—malignant glioma	0.00206	0.00498	CcSEcCtD
Topiramate—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.00205	0.00494	CcSEcCtD
Topiramate—Endocrine disorder—Temozolomide—malignant glioma	0.00203	0.00491	CcSEcCtD
Topiramate—Speech disorder—Carmustine—malignant glioma	0.00202	0.00489	CcSEcCtD
Topiramate—GRIA3—brain—malignant glioma	0.00196	0.00495	CbGeAlD
Topiramate—Speech disorder—Temozolomide—malignant glioma	0.00196	0.00473	CcSEcCtD
Topiramate—Disturbance in attention—Temozolomide—malignant glioma	0.00194	0.0047	CcSEcCtD
Topiramate—Breast pain—Temozolomide—malignant glioma	0.00193	0.00466	CcSEcCtD
Topiramate—Amenorrhoea—Temozolomide—malignant glioma	0.00192	0.00463	CcSEcCtD
Topiramate—Thinking abnormal—Carmustine—malignant glioma	0.0019	0.0046	CcSEcCtD
Topiramate—SCN1A—brainstem—malignant glioma	0.00189	0.00479	CbGeAlD
Topiramate—Drug interaction—Carmustine—malignant glioma	0.00188	0.00454	CcSEcCtD
Topiramate—GRIK2—brainstem—malignant glioma	0.00187	0.00474	CbGeAlD
Topiramate—Viral infection—Temozolomide—malignant glioma	0.00186	0.0045	CcSEcCtD
Topiramate—GRIA2—telencephalon—malignant glioma	0.00184	0.00466	CbGeAlD
Topiramate—GRIA1—medulla oblongata—malignant glioma	0.00182	0.0046	CbGeAlD
Topiramate—GRIK2—retina—malignant glioma	0.00181	0.00457	CbGeAlD
Topiramate—Gait disturbance—Carmustine—malignant glioma	0.00178	0.00431	CcSEcCtD
Topiramate—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00178	0.0043	CcSEcCtD
Topiramate—Coordination abnormal—Carmustine—malignant glioma	0.00177	0.00429	CcSEcCtD
Topiramate—Hearing impaired—Temozolomide—malignant glioma	0.00177	0.00427	CcSEcCtD
Topiramate—Pulmonary embolism—Carmustine—malignant glioma	0.00174	0.00421	CcSEcCtD
Topiramate—Gait disturbance—Temozolomide—malignant glioma	0.00172	0.00417	CcSEcCtD
Topiramate—CA7—midbrain—malignant glioma	0.00172	0.00434	CbGeAlD
Topiramate—Coordination abnormal—Temozolomide—malignant glioma	0.00171	0.00414	CcSEcCtD
Topiramate—Musculoskeletal pain—Temozolomide—malignant glioma	0.0017	0.00412	CcSEcCtD
Topiramate—Vaginal inflammation—Temozolomide—malignant glioma	0.00168	0.00407	CcSEcCtD
Topiramate—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00168	0.00407	CcSEcCtD
Topiramate—Pulmonary embolism—Temozolomide—malignant glioma	0.00168	0.00407	CcSEcCtD
Topiramate—Urinary incontinence—Carmustine—malignant glioma	0.00168	0.00406	CcSEcCtD
Topiramate—Depressed level of consciousness—Carmustine—malignant glioma	0.00168	0.00406	CcSEcCtD
Topiramate—SCN1A—telencephalon—malignant glioma	0.00168	0.00425	CbGeAlD
Topiramate—GRIA1—midbrain—malignant glioma	0.00166	0.00421	CbGeAlD
Topiramate—GRIK2—telencephalon—malignant glioma	0.00166	0.00421	CbGeAlD
Topiramate—Candida infection—Carmustine—malignant glioma	0.00166	0.00402	CcSEcCtD
Topiramate—Neuropathy—Carmustine—malignant glioma	0.00163	0.00395	CcSEcCtD
Topiramate—Influenza like illness—Temozolomide—malignant glioma	0.00163	0.00395	CcSEcCtD
Topiramate—Depressed level of consciousness—Temozolomide—malignant glioma	0.00162	0.00393	CcSEcCtD
Topiramate—Urinary incontinence—Temozolomide—malignant glioma	0.00162	0.00393	CcSEcCtD
Topiramate—GRIA1—spinal cord—malignant glioma	0.00162	0.00411	CbGeAlD
Topiramate—Candida infection—Temozolomide—malignant glioma	0.00161	0.00388	CcSEcCtD
Topiramate—Vaginal infection—Temozolomide—malignant glioma	0.00159	0.00384	CcSEcCtD
Topiramate—Neuropathy—Temozolomide—malignant glioma	0.00158	0.00382	CcSEcCtD
Topiramate—Neoplasm—Carmustine—malignant glioma	0.00157	0.00381	CcSEcCtD
Topiramate—Dry eye—Temozolomide—malignant glioma	0.00155	0.00376	CcSEcCtD
Topiramate—CA12—telencephalon—malignant glioma	0.00155	0.00393	CbGeAlD
Topiramate—Neoplasm—Temozolomide—malignant glioma	0.00152	0.00368	CcSEcCtD
Topiramate—Abnormal vision—Carmustine—malignant glioma	0.00152	0.00367	CcSEcCtD
Topiramate—Mental disability—Carmustine—malignant glioma	0.00151	0.00365	CcSEcCtD
Topiramate—GABRB2—brainstem—malignant glioma	0.00148	0.00373	CbGeAlD
Topiramate—Abnormal vision—Temozolomide—malignant glioma	0.00147	0.00355	CcSEcCtD
Topiramate—Phlebitis—Carmustine—malignant glioma	0.00147	0.00355	CcSEcCtD
Topiramate—Mental disability—Temozolomide—malignant glioma	0.00146	0.00353	CcSEcCtD
Topiramate—Diabetes mellitus—Carmustine—malignant glioma	0.00145	0.00351	CcSEcCtD
Topiramate—Ear pain—Temozolomide—malignant glioma	0.00143	0.00346	CcSEcCtD
Topiramate—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.0014	0.0034	CcSEcCtD
Topiramate—Eye pain—Carmustine—malignant glioma	0.0014	0.00338	CcSEcCtD
Topiramate—Gastroenteritis—Temozolomide—malignant glioma	0.00138	0.00333	CcSEcCtD
Topiramate—Vascular purpura—Temozolomide—malignant glioma	0.00137	0.0033	CcSEcCtD
Topiramate—Deafness—Temozolomide—malignant glioma	0.00137	0.0033	CcSEcCtD
Topiramate—Hepatic failure—Temozolomide—malignant glioma	0.00136	0.00329	CcSEcCtD
Topiramate—Eye pain—Temozolomide—malignant glioma	0.00135	0.00327	CcSEcCtD
Topiramate—Amnesia—Carmustine—malignant glioma	0.00135	0.00325	CcSEcCtD
Topiramate—Nasal congestion—Temozolomide—malignant glioma	0.00134	0.00324	CcSEcCtD
Topiramate—CA7—cerebellum—malignant glioma	0.00133	0.00336	CbGeAlD
Topiramate—GRIA2—midbrain—malignant glioma	0.00132	0.00334	CbGeAlD
Topiramate—SCN1A—medulla oblongata—malignant glioma	0.00132	0.00334	CbGeAlD
Topiramate—GRIA1—central nervous system—malignant glioma	0.00132	0.00333	CbGeAlD
Topiramate—GABRB2—telencephalon—malignant glioma	0.00131	0.00331	CbGeAlD
Topiramate—GABRG2—telencephalon—malignant glioma	0.00131	0.00331	CbGeAlD
Topiramate—GRIK2—medulla oblongata—malignant glioma	0.00131	0.0033	CbGeAlD
Topiramate—Hot flush—Temozolomide—malignant glioma	0.00131	0.00316	CcSEcCtD
Topiramate—GABRA1—brainstem—malignant glioma	0.0013	0.00329	CbGeAlD
Topiramate—Amnesia—Temozolomide—malignant glioma	0.0013	0.00314	CcSEcCtD
Topiramate—Menopausal symptoms—Temozolomide—malignant glioma	0.00129	0.00313	CcSEcCtD
Topiramate—GRIA2—spinal cord—malignant glioma	0.00129	0.00326	CbGeAlD
Topiramate—GRIA1—cerebellum—malignant glioma	0.00129	0.00326	CbGeAlD
Topiramate—Thirst—Temozolomide—malignant glioma	0.00128	0.0031	CcSEcCtD
Topiramate—Hyponatraemia—Carmustine—malignant glioma	0.00127	0.00307	CcSEcCtD
Topiramate—Purpura—Temozolomide—malignant glioma	0.00127	0.00306	CcSEcCtD
Topiramate—Diplopia—Carmustine—malignant glioma	0.00126	0.00306	CcSEcCtD
Topiramate—CA1—telencephalon—malignant glioma	0.00123	0.00311	CbGeAlD
Topiramate—Diplopia—Temozolomide—malignant glioma	0.00122	0.00295	CcSEcCtD
Topiramate—Face oedema—Carmustine—malignant glioma	0.00122	0.00295	CcSEcCtD
Topiramate—SCN1A—midbrain—malignant glioma	0.00121	0.00305	CbGeAlD
Topiramate—Affect lability—Temozolomide—malignant glioma	0.0012	0.00291	CcSEcCtD
Topiramate—GRIK2—midbrain—malignant glioma	0.00119	0.00302	CbGeAlD
Topiramate—Ataxia—Carmustine—malignant glioma	0.00119	0.00287	CcSEcCtD
Topiramate—Face oedema—Temozolomide—malignant glioma	0.00118	0.00285	CcSEcCtD
Topiramate—SCN1A—spinal cord—malignant glioma	0.00118	0.00298	CbGeAlD
Topiramate—CA9—cerebellum—malignant glioma	0.00117	0.00295	CbGeAlD
Topiramate—Liver function test abnormal—Carmustine—malignant glioma	0.00117	0.00282	CcSEcCtD
Topiramate—GRIK2—spinal cord—malignant glioma	0.00117	0.00295	CbGeAlD
Topiramate—Mood swings—Temozolomide—malignant glioma	0.00116	0.0028	CcSEcCtD
Topiramate—GABRA1—telencephalon—malignant glioma	0.00116	0.00292	CbGeAlD
Topiramate—Hypokalaemia—Carmustine—malignant glioma	0.00115	0.00278	CcSEcCtD
Topiramate—Ataxia—Temozolomide—malignant glioma	0.00115	0.00278	CcSEcCtD
Topiramate—Dehydration—Temozolomide—malignant glioma	0.00114	0.00275	CcSEcCtD
Topiramate—Muscular weakness—Carmustine—malignant glioma	0.00111	0.0027	CcSEcCtD
Topiramate—Hypokalaemia—Temozolomide—malignant glioma	0.00111	0.00269	CcSEcCtD
Topiramate—Breast disorder—Temozolomide—malignant glioma	0.0011	0.00267	CcSEcCtD
Topiramate—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.0011	0.00266	CcSEcCtD
Topiramate—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.0011	0.00266	CcSEcCtD
Topiramate—Dysphagia—Carmustine—malignant glioma	0.00109	0.00264	CcSEcCtD
Topiramate—CA4—brainstem—malignant glioma	0.00108	0.00274	CbGeAlD
Topiramate—CA7—brain—malignant glioma	0.00108	0.00273	CbGeAlD
Topiramate—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00108	0.0026	CcSEcCtD
Topiramate—Muscular weakness—Temozolomide—malignant glioma	0.00108	0.0026	CcSEcCtD
Topiramate—Abdominal distension—Temozolomide—malignant glioma	0.00106	0.00257	CcSEcCtD
Topiramate—Dysphagia—Temozolomide—malignant glioma	0.00106	0.00255	CcSEcCtD
Topiramate—GRIA2—central nervous system—malignant glioma	0.00105	0.00265	CbGeAlD
Topiramate—GRIA1—brain—malignant glioma	0.00105	0.00264	CbGeAlD
Topiramate—Pancytopenia—Carmustine—malignant glioma	0.00104	0.00251	CcSEcCtD
Topiramate—GABRB2—medulla oblongata—malignant glioma	0.00103	0.0026	CbGeAlD
Topiramate—GABRG2—medulla oblongata—malignant glioma	0.00103	0.0026	CbGeAlD
Topiramate—Sweating increased—Temozolomide—malignant glioma	0.00103	0.00249	CcSEcCtD
Topiramate—GRIA2—cerebellum—malignant glioma	0.00102	0.00259	CbGeAlD
Topiramate—Neutropenia—Carmustine—malignant glioma	0.00102	0.00247	CcSEcCtD
Topiramate—Bronchitis—Temozolomide—malignant glioma	0.00102	0.00245	CcSEcCtD
Topiramate—Pancytopenia—Temozolomide—malignant glioma	0.001	0.00242	CcSEcCtD
Topiramate—Neutropenia—Temozolomide—malignant glioma	0.000987	0.00239	CcSEcCtD
Topiramate—Dysuria—Temozolomide—malignant glioma	0.000987	0.00239	CcSEcCtD
Topiramate—Hyperglycaemia—Carmustine—malignant glioma	0.000985	0.00238	CcSEcCtD
Topiramate—Upper respiratory tract infection—Temozolomide—malignant glioma	0.000981	0.00237	CcSEcCtD
Topiramate—CA2—embryo—malignant glioma	0.000981	0.00248	CbGeAlD
Topiramate—Pneumonia—Carmustine—malignant glioma	0.00098	0.00237	CcSEcCtD
Topiramate—Pollakiuria—Temozolomide—malignant glioma	0.000975	0.00236	CcSEcCtD
Topiramate—Erectile dysfunction—Temozolomide—malignant glioma	0.000972	0.00235	CcSEcCtD
Topiramate—Depression—Carmustine—malignant glioma	0.000971	0.00235	CcSEcCtD
Topiramate—Photosensitivity reaction—Temozolomide—malignant glioma	0.000964	0.00233	CcSEcCtD
Topiramate—CA4—telencephalon—malignant glioma	0.000962	0.00243	CbGeAlD
Topiramate—Weight increased—Temozolomide—malignant glioma	0.000961	0.00232	CcSEcCtD
Topiramate—Renal failure—Carmustine—malignant glioma	0.000957	0.00231	CcSEcCtD
Topiramate—Weight decreased—Temozolomide—malignant glioma	0.000955	0.00231	CcSEcCtD
Topiramate—Neuropathy peripheral—Carmustine—malignant glioma	0.000955	0.00231	CcSEcCtD
Topiramate—SCN1A—central nervous system—malignant glioma	0.000955	0.00241	CbGeAlD
Topiramate—Hyperglycaemia—Temozolomide—malignant glioma	0.000952	0.0023	CcSEcCtD
Topiramate—Stomatitis—Carmustine—malignant glioma	0.000949	0.0023	CcSEcCtD
Topiramate—Urinary tract infection—Carmustine—malignant glioma	0.000947	0.00229	CcSEcCtD
Topiramate—Pneumonia—Temozolomide—malignant glioma	0.000947	0.00229	CcSEcCtD
Topiramate—GRIK2—central nervous system—malignant glioma	0.000945	0.00239	CbGeAlD
Topiramate—Infestation NOS—Temozolomide—malignant glioma	0.000941	0.00228	CcSEcCtD
Topiramate—Infestation—Temozolomide—malignant glioma	0.000941	0.00228	CcSEcCtD
Topiramate—GABRB2—midbrain—malignant glioma	0.00094	0.00238	CbGeAlD
Topiramate—GABRG2—midbrain—malignant glioma	0.00094	0.00238	CbGeAlD
Topiramate—Depression—Temozolomide—malignant glioma	0.000939	0.00227	CcSEcCtD
Topiramate—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000933	0.00226	CcSEcCtD
Topiramate—SCN1A—cerebellum—malignant glioma	0.000933	0.00236	CbGeAlD
Topiramate—GRIK2—cerebellum—malignant glioma	0.000924	0.00234	CbGeAlD
Topiramate—Neuropathy peripheral—Temozolomide—malignant glioma	0.000923	0.00223	CcSEcCtD
Topiramate—Stomatitis—Temozolomide—malignant glioma	0.000917	0.00222	CcSEcCtD
Topiramate—GABRB2—spinal cord—malignant glioma	0.000917	0.00232	CbGeAlD
Topiramate—GABRG2—spinal cord—malignant glioma	0.000917	0.00232	CbGeAlD
Topiramate—Urinary tract infection—Temozolomide—malignant glioma	0.000915	0.00221	CcSEcCtD
Topiramate—GABRA1—medulla oblongata—malignant glioma	0.000908	0.0023	CbGeAlD
Topiramate—CA2—brainstem—malignant glioma	0.000899	0.00227	CbGeAlD
Topiramate—CA12—central nervous system—malignant glioma	0.000883	0.00223	CbGeAlD
Topiramate—Sinusitis—Temozolomide—malignant glioma	0.000883	0.00213	CcSEcCtD
Topiramate—Haemoglobin—Carmustine—malignant glioma	0.000879	0.00212	CcSEcCtD
Topiramate—Haemorrhage—Carmustine—malignant glioma	0.000874	0.00211	CcSEcCtD
Topiramate—Hallucination—Carmustine—malignant glioma	0.00087	0.0021	CcSEcCtD
Topiramate—Hypoaesthesia—Carmustine—malignant glioma	0.00087	0.0021	CcSEcCtD
Topiramate—CA2—retina—malignant glioma	0.000867	0.00219	CbGeAlD
Topiramate—CA1—spinal cord—malignant glioma	0.000863	0.00218	CbGeAlD
Topiramate—Oedema peripheral—Carmustine—malignant glioma	0.000861	0.00208	CcSEcCtD
Topiramate—Connective tissue disorder—Carmustine—malignant glioma	0.000859	0.00208	CcSEcCtD
Topiramate—Haemoglobin—Temozolomide—malignant glioma	0.000849	0.00205	CcSEcCtD
Topiramate—Hepatitis—Temozolomide—malignant glioma	0.000845	0.00204	CcSEcCtD
Topiramate—Haemorrhage—Temozolomide—malignant glioma	0.000845	0.00204	CcSEcCtD
Topiramate—Visual impairment—Carmustine—malignant glioma	0.000843	0.00204	CcSEcCtD
Topiramate—Hallucination—Temozolomide—malignant glioma	0.000841	0.00203	CcSEcCtD
Topiramate—Hypoaesthesia—Temozolomide—malignant glioma	0.000841	0.00203	CcSEcCtD
Topiramate—Pharyngitis—Temozolomide—malignant glioma	0.000839	0.00203	CcSEcCtD
Topiramate—Urinary tract disorder—Temozolomide—malignant glioma	0.000834	0.00202	CcSEcCtD
Topiramate—Oedema peripheral—Temozolomide—malignant glioma	0.000832	0.00201	CcSEcCtD
Topiramate—GRIA2—brain—malignant glioma	0.000831	0.0021	CbGeAlD
Topiramate—Connective tissue disorder—Temozolomide—malignant glioma	0.00083	0.00201	CcSEcCtD
Topiramate—GABRA1—midbrain—malignant glioma	0.00083	0.0021	CbGeAlD
Topiramate—Urethral disorder—Temozolomide—malignant glioma	0.000828	0.002	CcSEcCtD
Topiramate—Eye disorder—Carmustine—malignant glioma	0.000817	0.00198	CcSEcCtD
Topiramate—Visual impairment—Temozolomide—malignant glioma	0.000814	0.00197	CcSEcCtD
Topiramate—Flushing—Carmustine—malignant glioma	0.000811	0.00196	CcSEcCtD
Topiramate—GABRA1—spinal cord—malignant glioma	0.00081	0.00205	CbGeAlD
Topiramate—Erythema multiforme—Temozolomide—malignant glioma	0.000799	0.00193	CcSEcCtD
Topiramate—CA2—telencephalon—malignant glioma	0.000798	0.00202	CbGeAlD
Topiramate—CA5B—central nervous system—malignant glioma	0.000792	0.002	CbGeAlD
Topiramate—Eye disorder—Temozolomide—malignant glioma	0.00079	0.00191	CcSEcCtD
Topiramate—Tinnitus—Temozolomide—malignant glioma	0.000788	0.0019	CcSEcCtD
Topiramate—Flushing—Temozolomide—malignant glioma	0.000784	0.0019	CcSEcCtD
Topiramate—Cardiac disorder—Temozolomide—malignant glioma	0.000784	0.0019	CcSEcCtD
Topiramate—Alopecia—Carmustine—malignant glioma	0.000773	0.00187	CcSEcCtD
Topiramate—SCN5A—central nervous system—malignant glioma	0.000768	0.00194	CbGeAlD
Topiramate—Angiopathy—Temozolomide—malignant glioma	0.000767	0.00185	CcSEcCtD
Topiramate—Mental disorder—Carmustine—malignant glioma	0.000766	0.00185	CcSEcCtD
Topiramate—Immune system disorder—Temozolomide—malignant glioma	0.000763	0.00185	CcSEcCtD
Topiramate—Mediastinal disorder—Temozolomide—malignant glioma	0.000762	0.00184	CcSEcCtD
Topiramate—Malnutrition—Carmustine—malignant glioma	0.000761	0.00184	CcSEcCtD
Topiramate—Erythema—Carmustine—malignant glioma	0.000761	0.00184	CcSEcCtD
Topiramate—Chills—Temozolomide—malignant glioma	0.000758	0.00183	CcSEcCtD
Topiramate—SCN1A—brain—malignant glioma	0.000758	0.00192	CbGeAlD
Topiramate—CA4—medulla oblongata—malignant glioma	0.000756	0.00191	CbGeAlD
Topiramate—GRIK2—brain—malignant glioma	0.000751	0.0019	CbGeAlD
Topiramate—Alopecia—Temozolomide—malignant glioma	0.000747	0.00181	CcSEcCtD
Topiramate—GABRB2—central nervous system—malignant glioma	0.000744	0.00188	CbGeAlD
Topiramate—GABRG2—central nervous system—malignant glioma	0.000744	0.00188	CbGeAlD
Topiramate—Mental disorder—Temozolomide—malignant glioma	0.00074	0.00179	CcSEcCtD
Topiramate—Back pain—Carmustine—malignant glioma	0.000736	0.00178	CcSEcCtD
Topiramate—Malnutrition—Temozolomide—malignant glioma	0.000736	0.00178	CcSEcCtD
Topiramate—Erythema—Temozolomide—malignant glioma	0.000736	0.00178	CcSEcCtD
Topiramate—GABRB2—cerebellum—malignant glioma	0.000727	0.00184	CbGeAlD
Topiramate—GABRG2—cerebellum—malignant glioma	0.000727	0.00184	CbGeAlD
Topiramate—Dysgeusia—Temozolomide—malignant glioma	0.00072	0.00174	CcSEcCtD
Topiramate—Vision blurred—Carmustine—malignant glioma	0.000717	0.00173	CcSEcCtD
Topiramate—Tremor—Carmustine—malignant glioma	0.000713	0.00172	CcSEcCtD
Topiramate—Back pain—Temozolomide—malignant glioma	0.000712	0.00172	CcSEcCtD
Topiramate—Anaemia—Carmustine—malignant glioma	0.000704	0.0017	CcSEcCtD
Topiramate—CA12—brain—malignant glioma	0.000701	0.00177	CbGeAlD
Topiramate—CA1—central nervous system—malignant glioma	0.0007	0.00177	CbGeAlD
Topiramate—Agitation—Carmustine—malignant glioma	0.000699	0.00169	CcSEcCtD
Topiramate—Vision blurred—Temozolomide—malignant glioma	0.000693	0.00168	CcSEcCtD
Topiramate—CA4—midbrain—malignant glioma	0.000691	0.00175	CbGeAlD
Topiramate—Tremor—Temozolomide—malignant glioma	0.000689	0.00167	CcSEcCtD
Topiramate—Ill-defined disorder—Temozolomide—malignant glioma	0.000682	0.00165	CcSEcCtD
Topiramate—Leukopenia—Carmustine—malignant glioma	0.000681	0.00165	CcSEcCtD
Topiramate—Anaemia—Temozolomide—malignant glioma	0.00068	0.00164	CcSEcCtD
Topiramate—Agitation—Temozolomide—malignant glioma	0.000676	0.00163	CcSEcCtD
Topiramate—CA4—spinal cord—malignant glioma	0.000674	0.00171	CbGeAlD
Topiramate—Malaise—Temozolomide—malignant glioma	0.000663	0.0016	CcSEcCtD
Topiramate—Vertigo—Temozolomide—malignant glioma	0.000661	0.0016	CcSEcCtD
Topiramate—Convulsion—Carmustine—malignant glioma	0.000659	0.00159	CcSEcCtD
Topiramate—Leukopenia—Temozolomide—malignant glioma	0.000658	0.00159	CcSEcCtD
Topiramate—GABRA1—central nervous system—malignant glioma	0.000657	0.00166	CbGeAlD
Topiramate—Hypertension—Carmustine—malignant glioma	0.000657	0.00159	CcSEcCtD
Topiramate—Palpitations—Temozolomide—malignant glioma	0.00065	0.00157	CcSEcCtD
Topiramate—Chest pain—Carmustine—malignant glioma	0.000648	0.00157	CcSEcCtD
Topiramate—Myalgia—Carmustine—malignant glioma	0.000648	0.00157	CcSEcCtD
Topiramate—Anxiety—Carmustine—malignant glioma	0.000646	0.00156	CcSEcCtD
Topiramate—GABRA1—cerebellum—malignant glioma	0.000642	0.00162	CbGeAlD
Topiramate—Cough—Temozolomide—malignant glioma	0.000642	0.00155	CcSEcCtD
Topiramate—Convulsion—Temozolomide—malignant glioma	0.000637	0.00154	CcSEcCtD
Topiramate—Hypertension—Temozolomide—malignant glioma	0.000635	0.00154	CcSEcCtD
Topiramate—CA5B—brain—malignant glioma	0.000629	0.00159	CbGeAlD
Topiramate—CA2—medulla oblongata—malignant glioma	0.000627	0.00159	CbGeAlD
Topiramate—Confusional state—Carmustine—malignant glioma	0.000626	0.00151	CcSEcCtD
Topiramate—Arthralgia—Temozolomide—malignant glioma	0.000626	0.00151	CcSEcCtD
Topiramate—Myalgia—Temozolomide—malignant glioma	0.000626	0.00151	CcSEcCtD
Topiramate—Anxiety—Temozolomide—malignant glioma	0.000624	0.00151	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000622	0.0015	CcSEcCtD
Topiramate—Oedema—Carmustine—malignant glioma	0.000621	0.0015	CcSEcCtD
Topiramate—Discomfort—Temozolomide—malignant glioma	0.000619	0.0015	CcSEcCtD
Topiramate—Infection—Carmustine—malignant glioma	0.000617	0.00149	CcSEcCtD
Topiramate—Dry mouth—Temozolomide—malignant glioma	0.000612	0.00148	CcSEcCtD
Topiramate—SCN5A—brain—malignant glioma	0.00061	0.00154	CbGeAlD
Topiramate—Thrombocytopenia—Carmustine—malignant glioma	0.000608	0.00147	CcSEcCtD
Topiramate—Tachycardia—Carmustine—malignant glioma	0.000606	0.00147	CcSEcCtD
Topiramate—Confusional state—Temozolomide—malignant glioma	0.000605	0.00146	CcSEcCtD
Topiramate—Oedema—Temozolomide—malignant glioma	0.0006	0.00145	CcSEcCtD
Topiramate—Infection—Temozolomide—malignant glioma	0.000596	0.00144	CcSEcCtD
Topiramate—Anorexia—Carmustine—malignant glioma	0.000592	0.00143	CcSEcCtD
Topiramate—GABRB2—brain—malignant glioma	0.000591	0.00149	CbGeAlD
Topiramate—GABRG2—brain—malignant glioma	0.000591	0.00149	CbGeAlD
Topiramate—Nervous system disorder—Temozolomide—malignant glioma	0.000589	0.00142	CcSEcCtD
Topiramate—Thrombocytopenia—Temozolomide—malignant glioma	0.000588	0.00142	CcSEcCtD
Topiramate—Skin disorder—Temozolomide—malignant glioma	0.000583	0.00141	CcSEcCtD
Topiramate—Hypotension—Carmustine—malignant glioma	0.00058	0.0014	CcSEcCtD
Topiramate—Hyperhidrosis—Temozolomide—malignant glioma	0.00058	0.0014	CcSEcCtD
Topiramate—CA2—midbrain—malignant glioma	0.000573	0.00145	CbGeAlD
Topiramate—Anorexia—Temozolomide—malignant glioma	0.000572	0.00138	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000566	0.00137	CcSEcCtD
Topiramate—Insomnia—Carmustine—malignant glioma	0.000562	0.00136	CcSEcCtD
Topiramate—CA2—spinal cord—malignant glioma	0.000559	0.00141	CbGeAlD
Topiramate—Paraesthesia—Carmustine—malignant glioma	0.000558	0.00135	CcSEcCtD
Topiramate—CA1—brain—malignant glioma	0.000556	0.0014	CbGeAlD
Topiramate—Dyspnoea—Carmustine—malignant glioma	0.000554	0.00134	CcSEcCtD
Topiramate—Somnolence—Carmustine—malignant glioma	0.000552	0.00134	CcSEcCtD
Topiramate—CA4—central nervous system—malignant glioma	0.000547	0.00138	CbGeAlD
Topiramate—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000547	0.00132	CcSEcCtD
Topiramate—Insomnia—Temozolomide—malignant glioma	0.000543	0.00131	CcSEcCtD
Topiramate—Decreased appetite—Carmustine—malignant glioma	0.00054	0.00131	CcSEcCtD
Topiramate—Paraesthesia—Temozolomide—malignant glioma	0.000539	0.0013	CcSEcCtD
Topiramate—Gastrointestinal disorder—Carmustine—malignant glioma	0.000536	0.0013	CcSEcCtD
Topiramate—Dyspnoea—Temozolomide—malignant glioma	0.000535	0.00129	CcSEcCtD
Topiramate—CA4—cerebellum—malignant glioma	0.000535	0.00135	CbGeAlD
Topiramate—Somnolence—Temozolomide—malignant glioma	0.000534	0.00129	CcSEcCtD
Topiramate—Constipation—Carmustine—malignant glioma	0.000531	0.00128	CcSEcCtD
Topiramate—Pain—Carmustine—malignant glioma	0.000531	0.00128	CcSEcCtD
Topiramate—Dyspepsia—Temozolomide—malignant glioma	0.000528	0.00128	CcSEcCtD
Topiramate—Decreased appetite—Temozolomide—malignant glioma	0.000522	0.00126	CcSEcCtD
Topiramate—GABRA1—brain—malignant glioma	0.000522	0.00132	CbGeAlD
Topiramate—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000518	0.00125	CcSEcCtD
Topiramate—Fatigue—Temozolomide—malignant glioma	0.000518	0.00125	CcSEcCtD
Topiramate—Constipation—Temozolomide—malignant glioma	0.000513	0.00124	CcSEcCtD
Topiramate—Pain—Temozolomide—malignant glioma	0.000513	0.00124	CcSEcCtD
Topiramate—Feeling abnormal—Carmustine—malignant glioma	0.000512	0.00124	CcSEcCtD
Topiramate—Gastrointestinal pain—Carmustine—malignant glioma	0.000508	0.00123	CcSEcCtD
Topiramate—Feeling abnormal—Temozolomide—malignant glioma	0.000495	0.0012	CcSEcCtD
Topiramate—Abdominal pain—Carmustine—malignant glioma	0.000491	0.00119	CcSEcCtD
Topiramate—Body temperature increased—Carmustine—malignant glioma	0.000491	0.00119	CcSEcCtD
Topiramate—Gastrointestinal pain—Temozolomide—malignant glioma	0.000491	0.00119	CcSEcCtD
Topiramate—Urticaria—Temozolomide—malignant glioma	0.000477	0.00115	CcSEcCtD
Topiramate—Body temperature increased—Temozolomide—malignant glioma	0.000475	0.00115	CcSEcCtD
Topiramate—Abdominal pain—Temozolomide—malignant glioma	0.000475	0.00115	CcSEcCtD
Topiramate—Hypersensitivity—Carmustine—malignant glioma	0.000458	0.00111	CcSEcCtD
Topiramate—CA2—central nervous system—malignant glioma	0.000454	0.00115	CbGeAlD
Topiramate—Asthenia—Carmustine—malignant glioma	0.000446	0.00108	CcSEcCtD
Topiramate—CA2—cerebellum—malignant glioma	0.000443	0.00112	CbGeAlD
Topiramate—Hypersensitivity—Temozolomide—malignant glioma	0.000442	0.00107	CcSEcCtD
Topiramate—CA4—brain—malignant glioma	0.000434	0.0011	CbGeAlD
Topiramate—Asthenia—Temozolomide—malignant glioma	0.000431	0.00104	CcSEcCtD
Topiramate—Diarrhoea—Carmustine—malignant glioma	0.000425	0.00103	CcSEcCtD
Topiramate—Pruritus—Temozolomide—malignant glioma	0.000425	0.00103	CcSEcCtD
Topiramate—Dizziness—Carmustine—malignant glioma	0.000411	0.000993	CcSEcCtD
Topiramate—Diarrhoea—Temozolomide—malignant glioma	0.000411	0.000993	CcSEcCtD
Topiramate—Dizziness—Temozolomide—malignant glioma	0.000397	0.00096	CcSEcCtD
Topiramate—Vomiting—Carmustine—malignant glioma	0.000395	0.000955	CcSEcCtD
Topiramate—Rash—Carmustine—malignant glioma	0.000392	0.000947	CcSEcCtD
Topiramate—Dermatitis—Carmustine—malignant glioma	0.000391	0.000946	CcSEcCtD
Topiramate—Headache—Carmustine—malignant glioma	0.000389	0.000941	CcSEcCtD
Topiramate—Vomiting—Temozolomide—malignant glioma	0.000382	0.000923	CcSEcCtD
Topiramate—Rash—Temozolomide—malignant glioma	0.000379	0.000915	CcSEcCtD
Topiramate—Dermatitis—Temozolomide—malignant glioma	0.000378	0.000914	CcSEcCtD
Topiramate—Headache—Temozolomide—malignant glioma	0.000376	0.000909	CcSEcCtD
Topiramate—Nausea—Carmustine—malignant glioma	0.000369	0.000892	CcSEcCtD
Topiramate—CA2—brain—malignant glioma	0.00036	0.000911	CbGeAlD
Topiramate—Nausea—Temozolomide—malignant glioma	0.000357	0.000862	CcSEcCtD
Topiramate—CYP3A4—central nervous system—malignant glioma	0.000293	0.00074	CbGeAlD
Topiramate—CA9—Cellular responses to stress—VEGFA—malignant glioma	8.27e-05	0.000433	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—VEGFA—malignant glioma	8.26e-05	0.000432	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—STAT3—malignant glioma	8.19e-05	0.000429	CbGpPWpGaD
Topiramate—CA7—Metabolism—GSTP1—malignant glioma	8.18e-05	0.000428	CbGpPWpGaD
Topiramate—CA5B—Metabolism—GSTP1—malignant glioma	8.18e-05	0.000428	CbGpPWpGaD
Topiramate—CA4—Metabolism—PTGS1—malignant glioma	8.17e-05	0.000428	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—IL1B—malignant glioma	8.11e-05	0.000425	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—CASP3—malignant glioma	8.09e-05	0.000424	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—RTEL1—malignant glioma	8.08e-05	0.000423	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	8.07e-05	0.000423	CbGpPWpGaD
Topiramate—CA5A—Metabolism—NCOR1—malignant glioma	8.05e-05	0.000422	CbGpPWpGaD
Topiramate—CA6—Metabolism—NCOR1—malignant glioma	8.05e-05	0.000422	CbGpPWpGaD
Topiramate—CA1—Metabolism—GSTT1—malignant glioma	8.01e-05	0.00042	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—GSTP1—malignant glioma	7.99e-05	0.000419	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—FGFR1—malignant glioma	7.98e-05	0.000418	CbGpPWpGaD
Topiramate—CA5B—Metabolism—CAT—malignant glioma	7.96e-05	0.000417	CbGpPWpGaD
Topiramate—CA7—Metabolism—CAT—malignant glioma	7.96e-05	0.000417	CbGpPWpGaD
Topiramate—CYP2C19—Metapathway biotransformation—GSTP1—malignant glioma	7.88e-05	0.000413	CbGpPWpGaD
Topiramate—CA2—Metabolism—PTGS1—malignant glioma	7.83e-05	0.00041	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—AKT1—malignant glioma	7.78e-05	0.000407	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—BRAF—malignant glioma	7.75e-05	0.000406	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—RAF1—malignant glioma	7.73e-05	0.000405	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—TFRC—malignant glioma	7.68e-05	0.000402	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	7.68e-05	0.000402	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—ERBB2—malignant glioma	7.65e-05	0.000401	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—RAF1—malignant glioma	7.62e-05	0.000399	CbGpPWpGaD
Topiramate—CA4—Metabolism—BCHE—malignant glioma	7.6e-05	0.000398	CbGpPWpGaD
Topiramate—CA12—Metabolism—GSTP1—malignant glioma	7.58e-05	0.000397	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—ERBB2—malignant glioma	7.54e-05	0.000395	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—KDR—malignant glioma	7.52e-05	0.000394	CbGpPWpGaD
Topiramate—CA7—Metabolism—NCOR1—malignant glioma	7.52e-05	0.000394	CbGpPWpGaD
Topiramate—CA5B—Metabolism—NCOR1—malignant glioma	7.52e-05	0.000394	CbGpPWpGaD
Topiramate—CA1—Metabolism—PTGS1—malignant glioma	7.51e-05	0.000393	CbGpPWpGaD
Topiramate—CA4—Metabolism—SLC5A5—malignant glioma	7.5e-05	0.000393	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—EGFR—malignant glioma	7.43e-05	0.000389	CbGpPWpGaD
Topiramate—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	7.42e-05	0.000389	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—MDM2—malignant glioma	7.41e-05	0.000388	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—RAF1—malignant glioma	7.38e-05	0.000387	CbGpPWpGaD
Topiramate—CA12—Metabolism—CAT—malignant glioma	7.37e-05	0.000386	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—MET—malignant glioma	7.36e-05	0.000385	CbGpPWpGaD
Topiramate—CA2—Metabolism—BCHE—malignant glioma	7.28e-05	0.000381	CbGpPWpGaD
Topiramate—CA2—Metabolism—SLC5A5—malignant glioma	7.19e-05	0.000377	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—MDM2—malignant glioma	7.1e-05	0.000372	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—NOTCH1—malignant glioma	7.08e-05	0.000371	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—RAF1—malignant glioma	7.08e-05	0.000371	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	7.05e-05	0.000369	CbGpPWpGaD
Topiramate—CA9—Metabolism—GSTT1—malignant glioma	7.05e-05	0.000369	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—KRAS—malignant glioma	7.02e-05	0.000368	CbGpPWpGaD
Topiramate—CA1—Metabolism—BCHE—malignant glioma	6.98e-05	0.000366	CbGpPWpGaD
Topiramate—CA12—Metabolism—NCOR1—malignant glioma	6.96e-05	0.000365	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—GSTT1—malignant glioma	6.94e-05	0.000363	CbGpPWpGaD
Topiramate—CA1—Metabolism—SLC5A5—malignant glioma	6.9e-05	0.000361	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—VEGFA—malignant glioma	6.86e-05	0.000359	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—PTPN11—malignant glioma	6.81e-05	0.000356	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—BRAF—malignant glioma	6.78e-05	0.000355	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	6.71e-05	0.000352	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—PPARG—malignant glioma	6.69e-05	0.00035	CbGpPWpGaD
Topiramate—CA9—Metabolism—PTGS1—malignant glioma	6.6e-05	0.000346	CbGpPWpGaD
Topiramate—CA6—Metabolism—CAV1—malignant glioma	6.56e-05	0.000344	CbGpPWpGaD
Topiramate—CA5A—Metabolism—CAV1—malignant glioma	6.56e-05	0.000344	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—MMP9—malignant glioma	6.56e-05	0.000344	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—PTGS1—malignant glioma	6.5e-05	0.00034	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—MDM2—malignant glioma	6.5e-05	0.00034	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—RAF1—malignant glioma	6.47e-05	0.000339	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—MMP9—malignant glioma	6.47e-05	0.000339	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—AKT2—malignant glioma	6.34e-05	0.000332	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—TP53—malignant glioma	6.25e-05	0.000327	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—MMP2—malignant glioma	6.14e-05	0.000321	CbGpPWpGaD
Topiramate—CA9—Metabolism—BCHE—malignant glioma	6.14e-05	0.000321	CbGpPWpGaD
Topiramate—CA7—Metabolism—CAV1—malignant glioma	6.13e-05	0.000321	CbGpPWpGaD
Topiramate—CA5B—Metabolism—CAV1—malignant glioma	6.13e-05	0.000321	CbGpPWpGaD
Topiramate—CA9—Metabolism—SLC5A5—malignant glioma	6.06e-05	0.000318	CbGpPWpGaD
Topiramate—CA4—Metabolism—GSTP1—malignant glioma	6.04e-05	0.000317	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PIK3CG—malignant glioma	5.98e-05	0.000313	CbGpPWpGaD
Topiramate—CA6—Metabolism—PIK3CG—malignant glioma	5.98e-05	0.000313	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—VEGFA—malignant glioma	5.89e-05	0.000309	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—TNF—malignant glioma	5.88e-05	0.000308	CbGpPWpGaD
Topiramate—CA4—Metabolism—CAT—malignant glioma	5.88e-05	0.000308	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—STAT3—malignant glioma	5.84e-05	0.000306	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—FGF2—malignant glioma	5.83e-05	0.000305	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—VEGFA—malignant glioma	5.81e-05	0.000304	CbGpPWpGaD
Topiramate—CA2—Metabolism—GSTP1—malignant glioma	5.79e-05	0.000303	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	5.78e-05	0.000303	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PPARG—malignant glioma	5.77e-05	0.000302	CbGpPWpGaD
Topiramate—CA6—Metabolism—PPARG—malignant glioma	5.77e-05	0.000302	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—MDM2—malignant glioma	5.68e-05	0.000297	CbGpPWpGaD
Topiramate—CA12—Metabolism—CAV1—malignant glioma	5.68e-05	0.000297	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—RAF1—malignant glioma	5.66e-05	0.000296	CbGpPWpGaD
Topiramate—CA2—Metabolism—CAT—malignant glioma	5.64e-05	0.000295	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	5.59e-05	0.000293	CbGpPWpGaD
Topiramate—CA7—Metabolism—PIK3CG—malignant glioma	5.58e-05	0.000292	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PIK3CG—malignant glioma	5.58e-05	0.000292	CbGpPWpGaD
Topiramate—CA1—Metabolism—GSTP1—malignant glioma	5.56e-05	0.000291	CbGpPWpGaD
Topiramate—CA4—Metabolism—NCOR1—malignant glioma	5.55e-05	0.000291	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—RAF1—malignant glioma	5.44e-05	0.000285	CbGpPWpGaD
Topiramate—CA1—Metabolism—CAT—malignant glioma	5.41e-05	0.000283	CbGpPWpGaD
Topiramate—CA7—Metabolism—PPARG—malignant glioma	5.39e-05	0.000282	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PPARG—malignant glioma	5.39e-05	0.000282	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—ERBB2—malignant glioma	5.38e-05	0.000282	CbGpPWpGaD
Topiramate—CA2—Metabolism—NCOR1—malignant glioma	5.32e-05	0.000279	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—EGFR—malignant glioma	5.3e-05	0.000278	CbGpPWpGaD
Topiramate—CA6—Metabolism—PIK3CD—malignant glioma	5.26e-05	0.000275	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PIK3CD—malignant glioma	5.26e-05	0.000275	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—EGFR—malignant glioma	5.22e-05	0.000274	CbGpPWpGaD
Topiramate—CA12—Metabolism—PIK3CG—malignant glioma	5.17e-05	0.000271	CbGpPWpGaD
Topiramate—CA1—Metabolism—NCOR1—malignant glioma	5.11e-05	0.000267	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—TNF—malignant glioma	5.05e-05	0.000265	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—KRAS—malignant glioma	5.01e-05	0.000262	CbGpPWpGaD
Topiramate—CA12—Metabolism—PPARG—malignant glioma	4.99e-05	0.000261	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—KRAS—malignant glioma	4.94e-05	0.000258	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PIK3CD—malignant glioma	4.91e-05	0.000257	CbGpPWpGaD
Topiramate—CA7—Metabolism—PIK3CD—malignant glioma	4.91e-05	0.000257	CbGpPWpGaD
Topiramate—CA9—Metabolism—GSTP1—malignant glioma	4.88e-05	0.000256	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—RTEL1—malignant glioma	4.86e-05	0.000255	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—GSTP1—malignant glioma	4.81e-05	0.000252	CbGpPWpGaD
Topiramate—CA9—Metabolism—CAT—malignant glioma	4.75e-05	0.000249	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	4.74e-05	0.000248	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—COX8A—malignant glioma	4.64e-05	0.000243	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—MMP9—malignant glioma	4.61e-05	0.000242	CbGpPWpGaD
Topiramate—CA6—Metabolism—PIK3CB—malignant glioma	4.58e-05	0.00024	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PIK3CB—malignant glioma	4.58e-05	0.00024	CbGpPWpGaD
Topiramate—CA12—Metabolism—PIK3CD—malignant glioma	4.55e-05	0.000238	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PTGS2—malignant glioma	4.54e-05	0.000238	CbGpPWpGaD
Topiramate—CA6—Metabolism—PTGS2—malignant glioma	4.54e-05	0.000238	CbGpPWpGaD
Topiramate—CA4—Metabolism—CAV1—malignant glioma	4.53e-05	0.000237	CbGpPWpGaD
Topiramate—CA9—Metabolism—NCOR1—malignant glioma	4.49e-05	0.000235	CbGpPWpGaD
Topiramate—CA2—Metabolism—CAV1—malignant glioma	4.34e-05	0.000227	CbGpPWpGaD
Topiramate—CA7—Metabolism—PIK3CB—malignant glioma	4.28e-05	0.000224	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PIK3CB—malignant glioma	4.28e-05	0.000224	CbGpPWpGaD
Topiramate—CA7—Metabolism—PTGS2—malignant glioma	4.24e-05	0.000222	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PTGS2—malignant glioma	4.24e-05	0.000222	CbGpPWpGaD
Topiramate—CA1—Metabolism—CAV1—malignant glioma	4.16e-05	0.000218	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	4.15e-05	0.000217	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—VEGFA—malignant glioma	4.14e-05	0.000217	CbGpPWpGaD
Topiramate—CA4—Metabolism—PIK3CG—malignant glioma	4.12e-05	0.000216	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—STAT3—malignant glioma	4.1e-05	0.000215	CbGpPWpGaD
Topiramate—CA4—Metabolism—PPARG—malignant glioma	3.98e-05	0.000208	CbGpPWpGaD
Topiramate—CA12—Metabolism—PIK3CB—malignant glioma	3.96e-05	0.000208	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PTEN—malignant glioma	3.96e-05	0.000207	CbGpPWpGaD
Topiramate—CA6—Metabolism—PTEN—malignant glioma	3.96e-05	0.000207	CbGpPWpGaD
Topiramate—CA2—Metabolism—PIK3CG—malignant glioma	3.95e-05	0.000207	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ASMT—malignant glioma	3.95e-05	0.000207	CbGpPWpGaD
Topiramate—CA12—Metabolism—PTGS2—malignant glioma	3.93e-05	0.000206	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	3.86e-05	0.000202	CbGpPWpGaD
Topiramate—CA2—Metabolism—PPARG—malignant glioma	3.82e-05	0.0002	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—RAF1—malignant glioma	3.81e-05	0.000199	CbGpPWpGaD
Topiramate—CA1—Metabolism—PIK3CG—malignant glioma	3.79e-05	0.000199	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—AKT1—malignant glioma	3.76e-05	0.000197	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—EGFR—malignant glioma	3.73e-05	0.000195	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—BCAN—malignant glioma	3.71e-05	0.000194	CbGpPWpGaD
Topiramate—CA7—Metabolism—PTEN—malignant glioma	3.7e-05	0.000194	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PTEN—malignant glioma	3.7e-05	0.000194	CbGpPWpGaD
Topiramate—CA9—Metabolism—CAV1—malignant glioma	3.66e-05	0.000192	CbGpPWpGaD
Topiramate—CA1—Metabolism—PPARG—malignant glioma	3.66e-05	0.000192	CbGpPWpGaD
Topiramate—CA4—Metabolism—PIK3CD—malignant glioma	3.63e-05	0.00019	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—TNF—malignant glioma	3.55e-05	0.000186	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—KRAS—malignant glioma	3.52e-05	0.000184	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—RAF1—malignant glioma	3.48e-05	0.000182	CbGpPWpGaD
Topiramate—CA2—Metabolism—PIK3CD—malignant glioma	3.48e-05	0.000182	CbGpPWpGaD
Topiramate—CA12—Metabolism—PTEN—malignant glioma	3.42e-05	0.000179	CbGpPWpGaD
Topiramate—CA9—Metabolism—PIK3CG—malignant glioma	3.33e-05	0.000175	CbGpPWpGaD
Topiramate—CA1—Metabolism—PIK3CD—malignant glioma	3.33e-05	0.000175	CbGpPWpGaD
Topiramate—CA9—Metabolism—PPARG—malignant glioma	3.22e-05	0.000168	CbGpPWpGaD
Topiramate—CA4—Metabolism—PIK3CB—malignant glioma	3.16e-05	0.000165	CbGpPWpGaD
Topiramate—CA4—Metabolism—PTGS2—malignant glioma	3.13e-05	0.000164	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—RAF1—malignant glioma	3.04e-05	0.000159	CbGpPWpGaD
Topiramate—CA2—Metabolism—PIK3CB—malignant glioma	3.03e-05	0.000159	CbGpPWpGaD
Topiramate—CA2—Metabolism—PTGS2—malignant glioma	3e-05	0.000157	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—IDH2—malignant glioma	2.99e-05	0.000157	CbGpPWpGaD
Topiramate—CA9—Metabolism—PIK3CD—malignant glioma	2.93e-05	0.000153	CbGpPWpGaD
Topiramate—CA1—Metabolism—PIK3CB—malignant glioma	2.9e-05	0.000152	CbGpPWpGaD
Topiramate—CA1—Metabolism—PTGS2—malignant glioma	2.88e-05	0.000151	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.82e-05	0.000148	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP2B6—malignant glioma	2.81e-05	0.000147	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PIK3CA—malignant glioma	2.79e-05	0.000146	CbGpPWpGaD
Topiramate—CA6—Metabolism—PIK3CA—malignant glioma	2.79e-05	0.000146	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—COX8A—malignant glioma	2.79e-05	0.000146	CbGpPWpGaD
Topiramate—CA4—Metabolism—PTEN—malignant glioma	2.73e-05	0.000143	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—AKT1—malignant glioma	2.64e-05	0.000138	CbGpPWpGaD
Topiramate—CA2—Metabolism—PTEN—malignant glioma	2.62e-05	0.000137	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PIK3CA—malignant glioma	2.61e-05	0.000137	CbGpPWpGaD
Topiramate—CA7—Metabolism—PIK3CA—malignant glioma	2.61e-05	0.000137	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—IDH1—malignant glioma	2.57e-05	0.000135	CbGpPWpGaD
Topiramate—CA9—Metabolism—PIK3CB—malignant glioma	2.55e-05	0.000134	CbGpPWpGaD
Topiramate—CA9—Metabolism—PTGS2—malignant glioma	2.53e-05	0.000133	CbGpPWpGaD
Topiramate—CA1—Metabolism—PTEN—malignant glioma	2.51e-05	0.000131	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SPHK1—malignant glioma	2.49e-05	0.00013	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP2C18—malignant glioma	2.44e-05	0.000128	CbGpPWpGaD
Topiramate—CA12—Metabolism—PIK3CA—malignant glioma	2.42e-05	0.000127	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ASMT—malignant glioma	2.37e-05	0.000124	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.3e-05	0.00012	CbGpPWpGaD
Topiramate—CA5A—Metabolism—AKT1—malignant glioma	2.28e-05	0.000119	CbGpPWpGaD
Topiramate—CA6—Metabolism—AKT1—malignant glioma	2.28e-05	0.000119	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—BCAN—malignant glioma	2.23e-05	0.000117	CbGpPWpGaD
Topiramate—CA9—Metabolism—PTEN—malignant glioma	2.21e-05	0.000116	CbGpPWpGaD
Topiramate—CA5B—Metabolism—AKT1—malignant glioma	2.13e-05	0.000112	CbGpPWpGaD
Topiramate—CA7—Metabolism—AKT1—malignant glioma	2.13e-05	0.000112	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.09e-05	0.00011	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.02e-05	0.000106	CbGpPWpGaD
Topiramate—CA12—Metabolism—AKT1—malignant glioma	1.97e-05	0.000103	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTT1—malignant glioma	1.97e-05	0.000103	CbGpPWpGaD
Topiramate—CA4—Metabolism—PIK3CA—malignant glioma	1.93e-05	0.000101	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PTGS1—malignant glioma	1.85e-05	9.68e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—PIK3CA—malignant glioma	1.85e-05	9.67e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.84e-05	9.64e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—IDH2—malignant glioma	1.8e-05	9.42e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—PIK3CA—malignant glioma	1.77e-05	9.27e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—BCHE—malignant glioma	1.72e-05	9e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SLC5A5—malignant glioma	1.7e-05	8.89e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.69e-05	8.86e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.61e-05	8.41e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.59e-05	8.33e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—AKT1—malignant glioma	1.57e-05	8.24e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PIK3CA—malignant glioma	1.56e-05	8.15e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—IDH1—malignant glioma	1.55e-05	8.1e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—AKT1—malignant glioma	1.51e-05	7.9e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SPHK1—malignant glioma	1.5e-05	7.84e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.47e-05	7.68e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—AKT1—malignant glioma	1.45e-05	7.58e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.39e-05	7.26e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTP1—malignant glioma	1.37e-05	7.16e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CAT—malignant glioma	1.33e-05	6.97e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—AKT1—malignant glioma	1.27e-05	6.66e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NCOR1—malignant glioma	1.26e-05	6.58e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTT1—malignant glioma	1.19e-05	6.21e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PTGS1—malignant glioma	1.11e-05	5.82e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—BCHE—malignant glioma	1.03e-05	5.41e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CAV1—malignant glioma	1.02e-05	5.36e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.02e-05	5.35e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	9.79e-06	5.12e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PIK3CG—malignant glioma	9.33e-06	4.89e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PPARG—malignant glioma	9e-06	4.72e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTP1—malignant glioma	8.22e-06	4.31e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PIK3CD—malignant glioma	8.2e-06	4.29e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CAT—malignant glioma	8e-06	4.19e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NCOR1—malignant glioma	7.56e-06	3.96e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PIK3CB—malignant glioma	7.15e-06	3.74e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PTGS2—malignant glioma	7.08e-06	3.71e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PTEN—malignant glioma	6.18e-06	3.23e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CAV1—malignant glioma	6.16e-06	3.23e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PIK3CG—malignant glioma	5.61e-06	2.94e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PPARG—malignant glioma	5.41e-06	2.84e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PIK3CD—malignant glioma	4.93e-06	2.58e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PIK3CA—malignant glioma	4.36e-06	2.28e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PIK3CB—malignant glioma	4.3e-06	2.25e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PTGS2—malignant glioma	4.26e-06	2.23e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PTEN—malignant glioma	3.71e-06	1.95e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—AKT1—malignant glioma	3.56e-06	1.86e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PIK3CA—malignant glioma	2.62e-06	1.37e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—AKT1—malignant glioma	2.14e-06	1.12e-05	CbGpPWpGaD
